Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
242
NCT03069014
Study of LM11A-31-BHS in Mild-moderate AD Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 15, 2017
Completion: Jun 8, 2020